| Adjunctive Ivermectin Mass Drug Administration for Malaria Control (NCT04844905) | London School of Hygiene and Tropical Medicine | 2021-05-03 |
| Moxidectin for LF, Cote d'Ivoire (DOLF) (NCT04410406) | Washington University School of Medicine | 2020-08-20 |
| Spontaneous Antigenemia in Loiasis (NCT04258670) | Washington University School of Medicine | 2020-01-23 |
| A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India (NCT02929121) | The Task Force for Global Health | 2019-01-15 |
| PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs ) (NCT03664063) | Lihir Medical Centre | 2018-09-01 |
| A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali (NCT02927496) | The Task Force for Global Health | 2018-06-19 |
| A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka (NCT02929134) | The Task Force for Global Health | 2018-02-16 |
| Twice Yearly Treatment for the Control of LF (NCT03036059) | Noguchi Memorial Institute for Medical Research | 2017-05-19 |
| Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis (NCT02899936) | Washington University School of Medicine | 2016-07-01 |
| Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study (NCT02509481) | Colorado State University | 2015-06-01 |
| Lymphatic Filariasis (LF) in Ivory Coast (NCT02974049) | University Hospitals Cleveland Medical Center | 2015-01-01 |
| Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa (NCT01975441) | University Hospitals Cleveland Medical Center | 2014-05-01 |
| Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis (NCT01903057) | Emory University | 2014-02-01 |
| Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast) (NCT02032043) | Washington University School of Medicine | 2014-02-01 |
| Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNG (NCT03268252) | University Hospitals Cleveland Medical Center | 2012-06-01 |
| Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India (NCT01629771) | Northwestern University | 2012-05-01 |
| Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia (NCT01905436) | Washington University School of Medicine | 2012-03-01 |
| Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis (NCT01905423) | Washington University School of Medicine | 2011-05-01 |
| Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi (NCT01213576) | London School of Hygiene and Tropical Medicine | 2009-01-01 |
| Effect of Albendazole Dose on Treatment of Lymphatic Filariasis (NCT00511004) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-07-01 |
| Research for Elimination of Lymphatic Filariasis (ICIDR) (NCT00406627) | Washington University School of Medicine | 2006-12-01 |
| Effect of Albendazole Dose on Clearance of Filarial Worms (NCT00375583) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-09-09 |
| Effect of Albendazole Dose on Clearance of Filarial Worms (NCT00339417) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-22 |
| Interaction Between HIV and Lymphatic Filariasis (NCT00295698) | DBL -Institute for Health Research and Development | 2001-08-01 |
| Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali (NCT02784743) | Centre d'Appui à la lutte contre la Maladie | 2001-05-01 |